Jiaping He
Impact in
Papers in
- Oncology 14
- CAR-T cell therapy research 13
-
- RNA Interference and Gene Delivery 2
- Co-authors
- Xun Ye (9 shared papers)Lianjun Shen (10 shared papers)Wei Cao (10 shared papers)Zhenguang Wang (5 shared papers)Weidong Han (2 shared papers)Qingming Yang (2 shared papers)Meixia Chen (2 shared papers)Haoyi Wang (2 shared papers)
In The Last Decade
Jiaping He
23 papers receiving 548 citations
Peers
Comparison fields: 5 of 56
- Oncology 384
- Urology 46
- Genetics 72
- Rheumatology 79
- Immunology 93
Countries citing papers authored by Jiaping He
This map shows the geographic impact of Jiaping He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaping He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaping He more than expected).
Fields of papers citing papers by Jiaping He
This network shows the impact of papers produced by Jiaping He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaping He. The network helps show where Jiaping He may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiaping He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 177 | |
| 2 | 2022 | 69 | |
| 3 | 2017 | 59 | |
| 4 | 2019 | 43 | |
| 5 | 2015 | 43 | |
| 6 | 2023 | 25 | |
| 7 | 2019 | 21 | |
| 8 | 2008 | 18 | |
| 9 | 2019 | 16 | |
| 10 | 2020 | 14 | |
| 11 | 2019 | 13 | |
| 12 | 2020 | 12 | |
| 13 | 2020 | 9 | |
| 14 | 2020 | 8 | |
| 15 | 2023 | 6 | |
| 16 | 2021 | 6 | |
| 17 | 2022 | 4 | |
| 18 | 2020 | 3 | |
| 19 | 2019 | 3 | |
| 20 | [Establishment of the methodology for quantifying lentiviral vector transcriptional read-through rate]. | 2013 | 2 |
About Jiaping He
Jiaping He is a scholar working on Oncology, Molecular Biology, Immunology, Genetics and Surgery, having authored 23 papers that have together received 555 indexed citations. Recurring topics across this work include CAR-T cell therapy research (13 papers), Virus-based gene therapy research (3 papers), Biosimilars and Bioanalytical Methods (3 papers), Mesenchymal stem cell research (2 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Pancreatitis Pathology and Treatment (2 papers), Caveolin-1 and cellular processes (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Oncology (384 citations), Urology (46 citations), Genetics (72 citations), Rheumatology (79 citations) and Immunology (93 citations). Jiaping He has collaborated with scholars based in China and Japan. Frequent co-authors include Xun Ye, Lianjun Shen, Wei Cao, Zhenguang Wang, Weidong Han, Qingming Yang, Meixia Chen, Haoyi Wang, Jing Nie and Kaichao Feng. Their work appears in journals such as Blood, Journal of Clinical Oncology, Gene, Cellular and Molecular Immunology and Tissue Engineering Part A.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.